Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables. https://t.co/iTo3XuvzPp
Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables. by Erhart F, Buchroithner J, Reitermaier R, Fischhuber K, Kli…
Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables https://t.co/sRyOcBU6fb
RT @DCell_papers: Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics in…
Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables. https://t.co/oRXAnzlZaW
#immunotherapy #Glioma BrainTumorDoc dwainwright_PhD Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables. https://t.c